Robert A. Anderson insider trades: bioAffinity Technologies (BIAF) SEC Form 4 filings
Companies
Where Robert reports to the SEC
About Robert A. Anderson's insider trades
Robert A. Anderson is a director at bioAffinity Technologies (BIAF). Robert has not reported an open-market purchase or sale.
Their filings also include grants and awards (4 filings), option exercises (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIAF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.